-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Biogen (BIIB): High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $99 at TD Cowen, Top Pick
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $90 at Oppenheimer
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $92 at Guggenheim
-
-
-
-
-
-
-
Ionis expands adaptive event for neurological disease communities
-
-
-
-
-
-
-
Stifel Reiterates Ionis Pharmaceuticals (IONS) at Hold, 'a highly-positive outcome for IONS'
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

